RXi Pharmaceuticals CEO Gerrit Dispersyn's 2019 pay jumps 55% to $659K
RXi Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: August 28, 2020
RXi Pharmaceuticals reported fiscal year 2019 executive compensation information on August 28, 2020.
In 2019, three executives at RXi Pharmaceuticals received on average a compensation package of $351K, a 32% decrease compared to previous year.
Average pay of disclosed executives at RXi Pharmaceuticals
Gerrit Dispersyn, Chief Executive Officer, received $659K in total, which increased by 55% compared to 2018. 56% of Dispersyn's compensation, or $372K, was in salary. Dispersyn also received $169K in non-equity incentive plan, $118K in stock awards, as well as $534 in other compensation.
John Barrett, Former Chief Development Officer, received a compensation package of $261K. 60% of the compensation package, or $157K, was in salary.
Geert Cauwenbergh, Chief Executive Officer, earned $132K in 2019, a 78% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on August 28, 2020.